C. Arce-Lara

发表

Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: the BMT CTN-0903/AMC-080 trial.

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis

P. Hari, M. Pasquini, R. Brazauskas, 2015, American journal of hematology.

Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis

P. Hari, M. Pasquini, A. D’Souza, 2015, Bone Marrow Transplantation.

Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.

P. Hari, M. Pasquini, A. D’Souza, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials

T. Bekaii-Saab, E. Kraut, G. Otterson, 2009, Cancer Chemotherapy and Pharmacology.

Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data.

M. Kelley, R. Sparapani, E. Gore, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach.

Vipul R Patel, V. Patel, D. Benson, 2007, Urology.

Cisplatin versus Carboplatin-Based Regimens for the Treatment of Patients with Metastatic Lung Cancer. An Analysis of Veterans Health Administration Data

M. Kelley, A. Szabo, Christina D. Williams, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.

P. Hari, N. Callander, L. F. Allen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation

P. Hari, M. Pasquini, X. Zhong, 2015, Bone Marrow Transplantation.

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

K. McMasters, Donald M Miller, G. Kloecker, 2006, Journal of Cancer Research and Clinical Oncology.

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma

P. Hari, M. Pasquini, A. D’Souza, 2019, Blood Cancer Journal.

Results of a Phase II Study of Propylene Glycol (PG)-Free, Captisol-Enabled Melphalan Conditioning for Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM)

P. Hari, N. Callander, L. F. Allen, 2015 .

Prospective, Multicenter Clinical Trial of Atorvastatin-Based Acute Graft-Versus-Host-Disease (aGVHD) Prophylaxis in Recipients of HLA-Matched Related Donor (MRD) and Matched Unrelated Donor (MUD) Allogeneic Hematopoietic Cell Transplantation (alloHCT)

P. Hari, M. Pasquini, M. Horowitz, 2016 .

P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 Inhibitors

A. Szabo, S. Menon, C. Arce-Lara, 2017 .

Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)

S. Jagannath, S. Lonial, P. Richardson, 2015 .

Single Center Experience of Prognostic Factors and Survival Outcomes Among Veterans with MDS: A Retrospective Analysis

S. Yellapragada, Z. Yasin, P. Lulla, 2010 .